Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

Stada Arzneimittel AG Partners with CR Sanjiu for Distribution in China

January 31, 2025
CompanyDrug

C2 Pharma Secures C-DMF Approval for Pilocarpine Nitrate API

November 4, 2024
CompanyDrug

SCG Cell Therapy’s SCG101 Receives Tacit Approval for Cholangiocarcinoma Clinical Trial in China

November 4, 2024
CompanyDrug

Akeso Biopharma’s Cadonilimab Meets Primary Endpoint in Phase III Cervical Cancer Study

November 4, 2024
CompanyDrug

RemeGen’s Telitacicept Receives Full Approval for Systemic Lupus Erythematosus in China

November 4, 2024
CompanyDeals

Boehringer Ingelheim Acquires T3 Pharmaceuticals to Boost Immuno-Oncology Portfolio

November 4, 2024
CompanyDrug

Bayer Halts Late-Stage Trial for Asundexian After Underperformance

November 4, 2024
CompanyDrug

Brii Biosciences’ BRII-179 Vaccine on Track for Breakthrough Therapy Designation in China

November 4, 2024
CompanyDeals

Venus Medtech Partners with Valgen Holding on DragonFly Valve System

November 4, 2024
CompanyDeals

Oculotronics Secures Pre-Series A Funding for Ophthalmic Surgical Robotics

November 4, 2024
CompanyDrug

Sumitomo Pharma Receives Chinese Approval for Xenleta to Treat Pneumonia

November 4, 2024
CompanyDrug

Gilead Announces Low-Carbon Bronchodilator Study for H1 2024

November 4, 2024
1 2 … 5 6 7 8 9 … 25 26
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up